Dr. Scott Gottlieb, practicing physician and Resident Fellow at the American Enterprise Institute spoke before a meeting of the International Society for Stem Cell Research, adressing the need for the Food and Drug Administration to adapt how it approaches pre-market regulation in order to properly address very novel areas of technology like gene editing and cell and gene therapy.
Recommended offer:
Get a custom quote for your event:
Get StartedSpeaker Search is a marketplace of speakers designed for talent buyers. We do not represent or manage speakers; instead, we provide event planners with the most comprehensive resource to discover and book the right talent.